Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C392479-20 20 µg (0.2 mg/ml) $371 
LS-C392479-100 100 µg (0.2 mg/ml) $574 
CD79A / CD79 Alpha Antibody - Formalin-fixed, paraffin-embedded human tonsil stained with anti-CD79a antibody (SPM550).  This image was taken for the unmodified form of this product. Other forms have not been tested.

Monoclonal Mouse anti‑Human CD79A / CD79 Alpha Antibody (clone SPM550, aa202‑216, IHC, IF) LS‑C392479

Monoclonal Mouse anti‑Human CD79A / CD79 Alpha Antibody (clone SPM550, aa202‑216, IHC, IF) LS‑C392479

Antibody:
CD79A / CD79 Alpha Mouse anti-Human Monoclonal (aa202-216) (SPM550) Antibody
Application:
IHC-P, IF
Reactivity:
Human
Format:
Unconjugated, Unmodified
Other formats:
Price
Catalog Number
$371
LS-C392479-20
Toll Free North America
206-374-1102
For Research Use Only

Overview

Antibody:
CD79A / CD79 Alpha Mouse anti-Human Monoclonal (aa202-216) (SPM550) Antibody
Application:
IHC-P, IF
Reactivity:
Human
Format:
Unconjugated, Unmodified
Other formats:

Specifications

Description
CD79 Alpha antibody LS-C392479 is an unconjugated mouse monoclonal antibody to human CD79 Alpha (CD79A) (aa202-216). Validated for IF and IHC.
Target
Human CD79A / CD79 Alpha
Synonyms
CD79A | CD79a antigen | Ig-alpha | MB-1 | MB-1 membrane glycoprotein | Surface IgM-associated protein | MB1
Host
Mouse
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
IgG1,k Monoclonal
Clone
SPM550
Conjugations
Unconjugated
Purification
Protein G purified
Modifications
Unmodified. Also available Azide-free, BSA-free.
Immunogen
Synthetic peptide (GTYQDVGSLNIADVQ, aa202-216) of the human protein. Percent identity by BLAST analysis: Human (93%); Ferret, Cat, Bat, Hamster, Horse, Pig, Guinea pig, Dog (87%); Sheep, Bovine, Elephant (80%); Mouse, Rat (73%).
Epitope
aa202-216
Specificity
Human CD79A / CD79 Alpha
Applications
  • IHC - Paraffin (0.25 - 0.5 µg/ml)
  • Immunofluorescence (0.5 - 1 µg/ml)
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
Usage
This antibody will stain many of the same lymphomas as anti-CD20, but also is more likely to stain B-lymphoblastic lymphoma/leukemia than is anti-CD20. Anti-CD79a also stains more cases of plasma cell myeloma and occasionally some types of endothelial cells as well. The optimal dilution of the anti-CD79a antibody for each application should be determined by the researcher. Staining of formalin-fixed tissues requires boiling tissue sections in 10mM citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes.
Presentation
1X PBS, 0.1 mg/ml BSA, 0.05% sodium azide
Storage
Store at 2°C to 8°C.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About CD79A / CD79 Alpha
P11912 NM_021601 NP_001774.1

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 4/26/2024